US 11077114
Stabilized formulations of CNS compounds
granted A61KA61K31/5377A61K9/0004
Quick answer
US patent 11077114 (Stabilized formulations of CNS compounds) held by Supernus Pharmaceuticals, Inc. expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Supernus Pharmaceuticals, Inc.
- Grant date
- Tue Aug 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K31/5377, A61K9/0004, A61K9/16, A61K9/1623